Abstract
Hip fracture rates in Taiwan are among the highest in the world. The aim of this study was to describe the trends of hip fracture hospitalizations among Taiwanese elderly (aged ≥ 65 years) and the trends of antiosteoporosis medication expenditure from 1999 to 2010. We conducted an ecological study using inpatient health care-utilization data from the Department of Health, and medication expenditure data from the IMS Health, Taiwan. The International Classification of Disease, Clinical Modification, 9th version, code 820 was used to identify hip fracture hospitalizations. Medications included alendronate, calcitonin, ibandronate, raloxifene, strontium ranelate, teriparatide, and zoledronic acid. Year 2010 was assigned as the reference point for age-standardized rates, currency exchange (to the US dollar), and discount rates. Over the 12-year study period, age-standardized hip fracture hospitalizations decreased by 2.7 % annually (p for trend < 0.001) for Taiwanese elders. The decline was more obvious among those aged ≥75 years (6.1 %). However, the number of hip fracture hospitalizations increased from 14,342 to 18,023. Total hospitalization costs increased by US$0.6 ± 0.2 million annually (p for trend = 0.002); however, the per capita costs decreased by US$23.0 ± 8.0 (p for trend = 0.017). The total medication expenditure increased 7.2-fold, from US$8.1 million to US$58.9 million, accounting for an increase in the overall pharmaceutical market by fivefold, from 3.4 to 15.9 ‰ (both p for trend < 0.001). From 1999 to 2010, there was a decline in hip fracture rates among elderly Taiwanese adults with a concomitant increase in antiosteoporosis medication expenditure.
Similar content being viewed by others
References
Cooper C, Cole ZA, Holroyd CR, Earl SC, Harvey NC, Dennison EM, Melton LJ, Cummings SR, Kanis JA (2011) Secular trends in the incidence of hip and other osteoporotic fractures. Osteoporos Int 22:1277–1288
Dimai HP, Svedbom A, Fahrleitner-Pammer A, Pieber T, Resch H, Zwettler E, Chandran M, Borgstrom F (2011) Epidemiology of hip fractures in Austria: evidence for a change in the secular trend. Osteoporos Int 22:685–692
Hiligsmann M, Bruyere O, Roberfroid D, Dubois C, Parmentier Y, Carton J, Detilleux J, Gillet P, Reginster JY (2012) Trends in hip fracture incidence and in the prescription of antiosteoporosis medications during the same time period in Belgium (2000–2007). Arthritis Care Res 64:744–750
Kannus P, Niemi S, Parkkari J, Palvanen M, Vuori I, Jarvinen M (2006) Nationwide decline in incidence of hip fracture. J Bone Miner Res 21:1836–1838
Maravic M, Taupin P, Landais P, Roux C (2011) Change in hip fracture incidence over the last 6 years in France. Osteoporos Int 22:797–801
McGowan B, Casey MC, Silke C, Whelan B, Bennett K (2012) Hospitalisations for fracture and associated costs between 2000 and 2009 in Ireland: a trend analysis. Osteoporos Int 24:849–857
Goettsch WG, de Jong RB, Kramarz P, Herings RM (2007) Developments of the incidence of osteoporosis in The Netherlands: a PHARMO study. Pharmacoepidemiol Drug Saf 16:166–172
Hartholt KA, Oudshoorn C, Zielinski SM, Burgers PT, Panneman MJ, van Beeck EF, Patka P, van der Cammen TJ (2011) The epidemic of hip fractures: are we on the right track? PloS One 6:e22227
Omsland TK, Holvik K, Meyer HE, Center JR, Emaus N, Tell GS, Schei B, Tverdal A, Gjesdal CG, Grimnes G, Forsmo S, Eisman JA, Sogaard AJ (2012) Hip fractures in Norway 1999–2008: time trends in total incidence and second hip fracture rates. A NOREPOS study. Eur J Epidemiol 27:807–814
Arias LH, Treceno C, Garcia-Ortega P, Rodriguez-Paredes J, Escudero A, Sainz M, Salado I, Velasco V, Carvajal A (2013) Hip fracture rates and bisphosphonate consumption in Spain. An ecologic study. Eur J Clin Pharmacol 69:559–564
Nilson F, Moniruzzaman S, Gustavsson J, Andersson R (2013) Trends in hip fracture incidence rates among the elderly in Sweden 1987–2009. J Public Health (Oxf) 35:125–131
Chevalley T, Herrmann FR, Guilley E, Hoffmeyer P, Rizzoli R (2011) General trend of hip fractures. Rev Med Suisse 7:1294–1298 [in French]
Lippuner K, Popp AW, Schwab P, Gitlin M, Schaufler T, Senn C, Perrelet R (2011) Fracture hospitalizations between years 2000 and 2007 in Switzerland: a trend analysis. Osteoporos Int 22:2487–2497
White SM, Griffiths R (2011) Projected incidence of proximal femoral fracture in England: a report from the NHS Hip Fracture Anaesthesia Network (HIPFAN). Injury 42:1230–1233
Leslie WD, O’Donnell S, Jean S, Lagace C, Walsh P, Bancej C, Morin S, Hanley DA, Papaioannou A (2009) Trends in hip fracture rates in Canada. JAMA 302:883–889
Wright NC, Saag KG, Curtis JR, Smith WK, Kilgore ML, Morrisey MA, Yun H, Zhang J, Delzell ES (2012) Recent trends in hip fracture rates by race/ethnicity among older US adults. J Bone Miner Res 27:2332–2352
Brauer CA, Coca-Perraillon M, Cutler DM, Rosen AB (2009) Incidence and mortality of hip fractures in the United States. JAMA 302:1573–1579
Cassell E, Clapperton A (2013) A decreasing trend in fall-related hip fracture incidence in Victoria, Australia. Osteoporos Int 24:99–109
Fielden J, Purdie G, Horne G, Devane P (2001) Hip fracture incidence in New Zealand, revisited. N Z Med J 114:154–156
Lau EM, Cooper C, Fung H, Lam D, Tsang KK (1999) Hip fracture in Hong Kong over the last decade—a comparison with the UK. J Public Health Med 21:249–250
Hagino H, Furukawa K, Fujiwara S, Okano T, Katagiri H, Yamamoto K, Teshima R (2009) Recent trends in the incidence and lifetime risk of hip fracture in Tottori, Japan. Osteoporos Int 20:543–548
Kanis JA, Oden A, McCloskey EV, Johansson H, Wahl DA, Cooper C (2012) A systematic review of hip fracture incidence and probability of fracture worldwide. Osteoporos Int 23:2239–2256
Shao CJ, Hsieh YH, Tsai CH, Lai KA (2009) A nationwide seven-year trend of hip fractures in the elderly population of Taiwan. Bone 44:125–129
Chie WC, Yang RS, Liu JP, Tsai KS (2004) High incidence rate of hip fracture in Taiwan: estimated from a nationwide health insurance database. Osteoporos Int 15:998–1002
Council for Economic Planning and Development (2012) National population estimate from 2012 to 2060. Executive Yuan, Taipei [in Chinese]
Bureau of Health Promotion, Department of Health, National Health Research Institute, The Taiwanese Osteoporosis Association (2011) Osteoporosis clinical treatment guideline, Taipei
Xu L, Lu A, Zhao X, Chen X, Cummings SR (1996) Very low rates of hip fracture in Beijing, People’s Republic of China the Beijing Osteoporosis Project. Am J Epidemiol 144:901–907
Koh LK, Saw SM, Lee JJ, Leong KH, Lee J (2001) Hip fracture incidence rates in Singapore 1991–1998. Osteoporos Int 12:311–318
Chang L, Hung JH (2008) The effects of the global budget system on cost containment and the quality of care: experience in Taiwan. Health Serv Manag Res 21:106–116
Cheng SH, Chen CC, Tsai SL (2012) The impacts of DRG-based payments on health care provider behaviors under a universal coverage system: a population-based study. Health Policy 107:202–208
Kristensen MT (2011) Factors affecting functional prognosis of patients with hip fracture. Eur J Phys Rehabil Med 47:257–264
Butler M, Forte ML, Joglekar SB, Swiontkowski MF, Kane RL (2011) Evidence summary: systematic review of surgical treatments for geriatric hip fractures. J Bone Joint Surg Am 93:1104–1115
Tamulaitiene M, Alekna V (2012) Incidence and direct hospitalisation costs of hip fractures in Vilnius, capital of Lithuania, in 2010. BMC Public Health 12:495
Yarzebski J, Granillo E, Spencer FA, Lessard D, Gurwitz JH, Gore JM, Goldberg RJ (2009) Changing trends (1986–2003) in the use of lipid lowering medication in patients hospitalized with acute myocardial infarction: a community-based perspective. Int J Cardiol 132:66–74
Cadarette SM, Carney G, Baek D, Gunraj N, Paterson JM, Dormuth CR (2012) Osteoporosis medication prescribing in British Columbia and Ontario: impact of public drug coverage. Osteoporos Int 23:1475–1480
Bureau of Health Promotion (2012) Adult smoking behavior surveillance system cross tabulation of important indicators 2004–2010 [in Chinese]
Wu SJ, Pan WH, Yeh NH, Chang HY, Hung SY (2011) Trends of food and nutrient intakes among Taiwanese adults: from NAHSIT 1993–1996 to 2005–2008. pp 1–30 [in Chinese]
Lin JR, Kao MD, Pan WH, Lin YS (2011) Diet supplement use of Taiwanese adults between 19–44 years of age: comparison of NAHSIT 1993–1996 to 2005–2008 data. pp 1–26 [in Chinese]
Pan WH, Wu HJ, Yeh CJ, Chuang SY, Chang HY, Yeh NH, Hsieh YT (2011) Diet and health trends in Taiwan: comparison of two nutrition and health surveys from 1993–1996 and 2005–2008. Asia Pac J Clin Nutr 20:238–250
Acknowledgements
The authors thank Novartis, Taiwan, for initiation of the study concept and MSD, Taiwan, for obtaining the IMS data. We also thank the secretary of the TOA for coordinating the study.
Author information
Authors and Affiliations
Corresponding author
Additional information
The authors have stated that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Chan, DC., Lee, YS., Wu, YJ. et al. A 12-Year Ecological Study of Hip Fracture Rates among Older Taiwanese Adults. Calcif Tissue Int 93, 397–404 (2013). https://doi.org/10.1007/s00223-013-9759-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00223-013-9759-x